Trial Outcomes & Findings for TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up (NCT NCT00336284)
NCT ID: NCT00336284
Last Updated: 2010-08-03
Results Overview
Average number of office-based implantable cardioverter defibrillator (ICD) follow-up visits in the Home Monitoring arm vs the Conventional (calendar-based) follow-up arm.
COMPLETED
PHASE4
1450 participants
12 months
2010-08-03
Participant Flow
Participant milestones
| Measure |
Home Monitoring
Home Monitoring programmed ON
|
Conventional
Home Monitoring programmed OFF
|
|---|---|---|
|
Overall Study
STARTED
|
977
|
473
|
|
Overall Study
COMPLETED
|
741
|
322
|
|
Overall Study
NOT COMPLETED
|
236
|
151
|
Reasons for withdrawal
| Measure |
Home Monitoring
Home Monitoring programmed ON
|
Conventional
Home Monitoring programmed OFF
|
|---|---|---|
|
Overall Study
Death
|
52
|
26
|
|
Overall Study
Lost to Follow-up
|
82
|
61
|
|
Overall Study
Withdrawal by Physician or Subject
|
102
|
64
|
Baseline Characteristics
TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up
Baseline characteristics by cohort
| Measure |
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
|
Conventional
n=431 Participants
Home Monitoring programmed OFF
|
Total
n=1339 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
63 years
STANDARD_DEVIATION 13 • n=5 Participants
|
64 years
STANDARD_DEVIATION 12 • n=7 Participants
|
64 years
STANDARD_DEVIATION 13 • n=5 Participants
|
|
Sex: Female, Male
Female
|
254 Participants
n=5 Participants
|
116 Participants
n=7 Participants
|
370 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
654 Participants
n=5 Participants
|
315 Participants
n=7 Participants
|
969 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
896 participants
n=5 Participants
|
425 participants
n=7 Participants
|
1321 participants
n=5 Participants
|
|
Region of Enrollment
Canada
|
12 participants
n=5 Participants
|
6 participants
n=7 Participants
|
18 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: Only participants who completed at least one follow-up visit are included in the analyses.
Average number of office-based implantable cardioverter defibrillator (ICD) follow-up visits in the Home Monitoring arm vs the Conventional (calendar-based) follow-up arm.
Outcome measures
| Measure |
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
|
Conventional
n=431 Participants
Home Monitoring programmed OFF
|
|---|---|---|
|
Home Monitoring Effectiveness
|
2.1 In-office ICD follow-up per patient year
Interval 0.0 to 45.6
|
3.8 In-office ICD follow-up per patient year
Interval 0.0 to 19.2
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: Safety Event Rate includes events occuring within 12 months of enrollment for participants with at least 1 follow-up.
Percentage of participants experiencing death, incidence of stroke, or event(s) requiring surgical intervention. Outcome measure time frame is 12 months.
Outcome measures
| Measure |
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
|
Conventional
n=431 Participants
Home Monitoring programmed OFF
|
|---|---|---|
|
Percent of Participants Experiencing Death, Incidence of Stroke, or Event Requiring Surgical Intervention.
|
10.4 Percentage of participants
|
10.4 Percentage of participants
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: Only participants with at least one follow-up are included in the analyses.
Detection time relative to onset of cardiac events (atrial fibrillation, ventricular tachycardia, ventricular fibrillation).
Outcome measures
| Measure |
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
|
Conventional
n=431 Participants
Home Monitoring programmed OFF
|
|---|---|---|
|
Early Detection of Cardiac Events
|
13.98 Days
Interval 0.0 to 256.0
|
45.34 Days
Interval 0.0 to 287.0
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: Only participants with at least one follow-up are included in the analyses
Percentage of total patient initiated inqueries that result in ER or office follow-up visits.
Outcome measures
| Measure |
Home Monitoring
n=908 Participants
Home Monitoring programmed ON
|
Conventional
n=431 Participants
Home Monitoring programmed OFF
|
|---|---|---|
|
Patient Initiated Follow-up
|
92.7 percent of patient initiated follow-ups
|
100 percent of patient initiated follow-ups
|
Adverse Events
Home Monitoring
Conventional
Serious adverse events
| Measure |
Home Monitoring
n=977 participants at risk
Home Monitoring programmed ON
|
Conventional
n=473 participants at risk
Home Monitoring programmed OFF
|
|---|---|---|
|
Surgical and medical procedures
Ablation procedure
|
0.51%
5/977 • Number of events 5 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.85%
4/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Aborted upgrade procedure
|
0.00%
0/977 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.21%
1/473 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Cardiac disorders
Cardiac related hospitalizations
|
4.6%
45/977 • Number of events 64 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
6.6%
31/473 • Number of events 35 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Catheterization/PCI procedure
|
1.5%
15/977 • Number of events 16 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Coronary artery bypass graft procedure
|
0.31%
3/977 • Number of events 3 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
General disorders
Death
|
5.3%
52/977 • Number of events 52 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
5.5%
26/473 • Number of events 26 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Device change-out
|
0.82%
8/977 • Number of events 8 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.63%
3/473 • Number of events 3 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Device revision
|
1.7%
17/977 • Number of events 18 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
1.5%
7/473 • Number of events 7 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Heart transplant
|
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
IVC filter implanted
|
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
LV assist device implanted
|
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Lead revision/explant/replacement
|
1.6%
16/977 • Number of events 16 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
1.1%
5/473 • Number of events 5 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
General disorders
Non-cardiac related hospitalizations
|
1.6%
16/977 • Number of events 20 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Non-cardiac surgical interventions
|
0.72%
7/977 • Number of events 8 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.63%
3/473 • Number of events 4 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Permacath for dialysis and endoscopy
|
0.10%
1/977 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.00%
0/473 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
|
Surgical and medical procedures
Tighten loose set screw
|
0.00%
0/977 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
0.21%
1/473 • Number of events 1 • 15 Months
Strokes or complications that lead to a surgical intervention were required to be reported. Complications that led to a surgical intervention include but are not limited to a lead revision, cardiac interventional procedure, or device replacement. Other AEs were reported at the discretion of the investigator and may include non-cardiac events.
|
Other adverse events
Adverse event data not reported
Additional Information
Justin Michalski, M.S. / Clinical Studies Engineer
Biotronik, Inc.
Results disclosure agreements
- Principal investigator is a sponsor employee The investigator agrees to provide copies of any abstracts, papers or manuscripts to the Sponsor for review within a reasonable period prior to submittal for publication. BIOTRONIK limits its review to a determination of whether Confidential Information (CI) is disclosed and may not attempt to censor or in any way interfere with the investigator's presentation or conclusions beyond the extent necessary to protect CI or to allow to protect its rights in patentable or copyrightable material.
- Publication restrictions are in place
Restriction type: OTHER